Company: CMND
Filing Date: 2025-09-15
Form Type: POS AM
Source: 0001213900-25-087398
Chunk: 12

Company: Clearmind Medicine Inc.
Filing Date: 2025-09-15
Form: POS AM
Chunk 12
---
 the Securities Act, as modified by the JOBS Act. As such,
we are eligible to, and intend to, take advantage of certain exemptions from various reporting requirements applicable to other public
companies that are not “emerging growth companies” such as not being required to comply with the auditor attestation requirements
of Section 404 of the Sarbanes-Oxley Act of 2002. We could remain an “emerging growth company” for up to five years,
which will be December 31, 2027, or until the earliest of (a) the last day of the first fiscal year in which our annual gross revenue
exceeds $1.235 billion, (b) the date that we become a “large accelerated filer” as defined in Rule 12b-2 under
the Securities Exchange Act of 1934, as amended, or the Exchange Act, which would occur if the market value of the securities that are
held by non-affiliates exceeds $700 million as of the last business day of our most recently completed second fiscal quarter, or
(c) the date on which we have issued more than $1 billion in nonconvertible debt during the preceding three-year period.

Foreign Private Issuer

We are subject to the information reporting requirements
of the Exchange Act that are applicable to “foreign private issuers,” and under those requirements we will file reports with
the United States Securities and Exchange Commission, or SEC. As a foreign private issuer, we are not subject to the same requirements
that are imposed upon U.S. domestic issuers by the SEC. Under the Exchange Act, we are subject to reporting obligations that, in certain
respects, are less detailed and less frequent than those of U.S. domestic reporting companies. For example, although we report our financial
results on a quarterly basis, we will not be required to issue quarterly reports, proxy statements that comply with the requirements
applicable to U.S. domestic reporting companies, or individual executive compensation information that is as detailed as that required
of U.S. domestic reporting companies. We also have four months after the end of each fiscal year to file our annual reports with the
SEC and are not required to file current reports as frequently or promptly as U.S. domestic reporting companies. We also present financial
statements pursuant to IFRS instead of pursuant to U.S. generally accepted accounting principles. Furthermore, although the members of
our management and supervisory boards will be required to notify the Israeli Securities Authority,